Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2014-07-16
Original SEC Filing: Click here

---

Webplus: SVA/20140716/6-K/2_EX-99.1/000.htm SEC Original: v383993_ex99-1.htm
Sinovac Announces Favorable Reduction in Value Added Tax Rate BEIJING, June 25, 2014 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that the value added tax (or “VAT”) rate applied to the sales of Sinovac’s vaccine products will be reduced to 3% from the current rate of 6%, according to a

---

---

Webplus: SVA/20140716/6-K/1/000.htm SEC Original: v383993_6k.htm

---

Company Information:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2014-07-16CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085